Medplus Health Services Limited IPO GMP : Medplus IPO Quote, Date, Price
The company is the second largest pharmacy retailer in India, in terms of (i) revenue from operations for the financial year 2021, and (ii) number of stores as of March 31, 2021, according to the Technopak Report.
It offers a wide range of products, including (i) pharmaceutical and wellness products, including medicines, vitamins, medical devices and test kits, and (ii) fast-moving consumer goods, such as home and personal care products, including toiletries, baby care products, soaps and detergents, and sanitizers.
Its number of stores has grown since the conception of its business and, as of September 30, 2021, the company has operated 546 stores in Karnataka, 475 stores in Tamil Nadu, 474 stores in Telangana, 297 stores in Andhra Pradesh, 224 stores in West Bengal, 221 stores in Maharashtra and 89 stores in Odisha.
In terms of number of stores as of March 31, 2021, it ranked 1st in Chennai and Bangalore, and 2nd in Hyderabad and Kolkata, according to the Technopak Report.
Price Range : Rs. 780 – 796
Minimum Investment : Rs.14040
Minimum Quantity: 18
Dates
Offer End | : | 15 Dec 2021 |
Allotment Finalisation | : | 20 Dec 2021 |
Refund Initiation | : | 21 Dec 2021 |
Listing | : | 23 Dec 2021 |
Map my India Limited IPO GMP : Map my India IPO Quote, Date, Price
Strengths
India’s second largest pharmacy retailer
|
Successful track record of expansion
|
High density store network enhancing omni-channel proposition
|
Risks
Non-compliance with and changes in drug and dispensary laws and other applicable regulations
|
Changes in its product mix may impact the results of operation
|
The extent to which COVID-19 may affect the business and operations in the future |
Be the first to comment